menu search

New preliminary clinical data on potential of opus aav-based gene therapy for rare inherited retinal disease to be presented at the american academy of ophthalmology annual conference 2023

Data to be presented as part of gene augmentation therapy presentation RALEIGH, N.C., Nov. 03, 2023 (GLOBE NEWSWIRE) — Opus G...

November 3, 2023, 7:43 pm

Hrmy vs. regn: which stock should value investors buy now?

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Har...

November 3, 2023, 12:47 pm

Fulgent genetics, inc. (flgt) q3 2023 earnings call transcript

Fulgent Genetics, Inc. (NASDAQ:FLGT ) Q3 2023 Earnings Call Transcript November 3, 2023 8:30 AM ET Comp...

November 3, 2023, 12:22 pm

eneti inc. to announce third quarter 2023 results and have a conference call on november 14, 2023

MONACO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- eneti Inc. (NYSE: NETI) (the “Company”) plans to announce...

November 3, 2023, 6:46 am

Lexeo therapeutics announces pricing of initial public offering

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage geneti<...

November 3, 2023, 1:51 am

Pbyi or tech: which is the better value stock right now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Puma Biotech ...

November 2, 2023, 12:47 pm

Genetic toxicology testing market expected to reach a market value of us$ 4.56 billion: growing demand for personalized medicine spurs growth, according to persistence market research

The global genetic toxicology testing market is expected to grow rapidly in the coming years, driven by...

November 1, 2023, 10:04 am

Why is mainz biomed (mynz) stock moving today?

Mainz Biomed (NASDAQ: MYNZ ) stock is on the move Wednesday after the molecular genetics cancer diagno...

November 1, 2023, 8:40 am

Is invitae stock a buy now?

Invitae's revenue has climbed over time thanks to a vast portfolio of genetic tests. At the same time, ...

November 1, 2023, 5:30 am

Myriad genetics to release third quarter financial results on november 6, 2023

SALT LAKE CITY, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in g<...

October 31, 2023, 4:05 pm

Omega therapeutics presents new preclinical data demonstrating pre-transcriptional modulation of multiple cxcl genes by a single epigenomic controller

Coordinated modulation of epigenetic profile of CXCL1-8 genes with corresponding downregulation of gene...

October 31, 2023, 11:00 am

Fulcrum therapeutics to host third quarter 2023 financial results conference call and webcast on tuesday, november 7, 2023, at 8:00 a.m. et

CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutica...

October 31, 2023, 8:50 am

23andme to offer clients personalized action plans based on genetic and other health data

23andMe Holding Co. ME, +0.39% said Tuesday it's launching a health action plan that will offer its clients personalized recommendations based on g...

October 31, 2023, 8:14 am

Crsp stock: fda considers additional review of crispr therapeutics gene therapy

Shares of genetic engineering specialist CRISPR Therapeutics (NASDAQ: CRSP ) moved up modestly on Frida...

October 27, 2023, 3:10 pm

Lgnd vs. ilmn: which stock is the better value option?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider eit...

October 26, 2023, 12:47 pm

Reneo pharmaceuticals announces poster presentation at upcoming scientific meetings

IRVINE, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the ...

October 25, 2023, 11:50 am

23andme notifies customers of data breach into its 'dna relatives' feature

Genetics testing company 23andMe on Tuesday sent emails to several customers to inform them of a breach...

October 24, 2023, 6:15 pm

Sophia genetics to announce financial results for the third quarter of fiscal 2023 on november 7, 2023

BOSTON and GENEVA, Switzerland, Oct. 24, 2023 (GLOBE NEWSWIRE) — SOPHiA GenetiCS SA (Nasdaq: SOPH), a...

October 24, 2023, 9:50 am

Bull of the day: neogenomics (neo)

NeoGenomics ( NEO ) is a small-cap provider of cancer genetics diagnostics. They boast one of the most ...

October 24, 2023, 6:46 am

Sophia genetics to announce financial results for the third quarter of fiscal 2023 on november 7, 2023

BOSTON and GENEVA, Switzerland, Oct. 24, 2023 (GLOBE NEWSWIRE) -- SOPHiA GenetiCS SA (Nasdaq: SOPH), a ...

October 24, 2023, 5:50 am


Search within

Pages Search Results: